Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease—a consensus statement of the European Society of Endocrine Surgeons (ESES)

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Langenbeck's archives of surgery (Print)

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00423-013-1139-5PMID 24297502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgical Curability of Medullary Thyroid Cancer in Multiple Endocrine Neoplasia 2B: A Changing Perspective

  2014cited by this paper
• Guidelines for the management of thyroid cancer

  2014cited by this paper
• Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?

  2013cited by this paper
• Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level

  2013cited by this paper
• Morbidity following thyroid surgery: does surgeon volume matter?

  2013cited by this paper
• Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.

  2013cited by this paper
• Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe

  2013cited by this paper
• Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?

  2013cited by this paper
• German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

  2013cited by this paper
• Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.

  2013cited by this paper
• The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association

  2013cited by this paper
• Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening

  2012cited by this paper
• Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.

  2012cited by this paper
• The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

  2012cited by this paper
• 2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer

  2012cited by this paper
• Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival

  2012cited by this paper
• Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.

  2011cited by this paper
• RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

  2011cited by this paper
• Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines.

  2011cited by this paper
• Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.

  2011cited by this paper
• Screening for Medullary Thyroid Carcinoma with Serum Calcitonin Measurements in Patients with Thyroid Nodules in the United States and Canada

  2011cited by this paper
• Management of medullary thyroid carcinoma and MEN2 syndromes in childhood

  2011cited by this paper
• Influence of lymph node metastases on survival in pediatric medullary thyroid cancer.

  2010cited by this paper
• The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer

  2010cited by this paper
• UvA-DARE ( Digital Academic Repository ) Factors Predicting Outcome of Total Thyroidectomy in Young Patients with Multiple Endocrine Neoplasia Type 2 : A Nationwide Long-Term Follow-up Study

  2010influential reference
• Medullary carcinoma: Clinical practice guidelines in oncology™

  2010cited by this paper
• Individualization of Lymph Node Dissection in RET (Rearranged During Transfection) Carriers at Risk for Medullary Thyroid Cancer: Value of Pretherapeutic Calcitonin Levels

  2010cited by this paper
• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cited by this paper
• Biomarker-based risk stratification for previously untreated medullary thyroid cancer.

  2010cited by this paper
• The prevalence of occult medullary thyroid carcinoma at autopsy.

  2010cited by this paper
• Medullary carcinoma.

  2010cited by this paper
• Individualization of Lymph Node Dissection in RET (Rearranged During Transfection) Carriers at Risk for Medullary Thyroid Cancer: Value of Pretherapeutic Calcitonin Levels

  2009cited by this paper
• A Perspective from Pediatric Endocrinology on the Hereditary Medullary Thyroid Carcinoma Syndromes

  2009cited by this paper
• Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma

  2009cited by this paper
• American Thyroid Association Guidelines for Management of Medullary Thyroid Cancer: An Adult Endocrinology Perspective

  2009cited by this paper
• Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.

  2009cited by this paper
• Extrathyroidal Manifestations of Multiple Endocrine Neoplasia Type 2

  2009cited by this paper
• Prophylactic Thyroidectomy in RET Carriers at Risk for Hereditary Medullary Thyroid Cancer

  2009cited by this paper
• Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

  2009influential reference
• Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

  2008cited by this paper
• Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

  2008cited by this paper
• Sporadic hypercalcitoninemia: clinical and therapeutic consequences.

  2008influential reference
• Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.

  2007cited by this paper
• Genotype-Phenotype Based Surgical Concept of Hereditary Medullary Thyroid Carcinoma

  2007cited by this paper
• RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

  2007cited by this paper
• Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery.

  2007cited by this paper
• Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.

  2007cited by this paper
• Measurement of calcitonin by immunoassay analyzers

  2007cited by this paper
• What the surgeon of tomorrow needs to know about evidence-based surgery.

  2006cited by this paper
• Determinants of life expectancy in medullary thyroid cancer: age does not matter

  2006cited by this paper
• Normal Range of Calcitonin in Children Measured by a Chemiluminescent Two-Site Immunometric Assay

  2006cited by this paper
• Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.

  2006cited by this paper
• Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study

  2006cited by this paper
• Reference intervals for serum calcitonin in men, women, and children.

  2004cited by this paper
• Multiple Endocrine Neoplasia 2B Syndrome due to Codon 918 Mutation: Clinical Manifestation and Course in Early and Late Onset Disease

  2004cited by this paper
• Early malignant progression of hereditary medullary thyroid cancer.

  2003cited by this paper
• Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations.

  2003cited by this paper
• Recommendations for reporting C cell pathology of the thyroid.

  2002cited by this paper
• Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.

  2002cited by this paper
• CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

  2001cited by this paper
• Sporadic Versus Familial Medullary Thyroid Microcarcinoma: A Histopathologic Study of 50 Consecutive Patients

  2001cited by this paper
• Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.

  2001cited by this paper
• C-Cell hyperplasia and medullary thyroid microcarcinoma

  2001cited by this paper
• Guidelines for diagnosis and therapy of MEN type 1 and type 2.

  2001cited by this paper
• Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation

  2000cited by this paper
• Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996

  2000cited by this paper
• Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996

  2000cited by this paper
• Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma

  1999cited by this paper
• Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.

  1999cited by this paper
• Evaluation of Routine Basal Serum Calcitonin Measurement for Early Diagnosis of Medullary Thyroid Carcinoma in Seven Hundred Seventy-Three Patients with Nodular Goiter

  1999cited by this paper
• Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience

  1998cited by this paper
• Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

  1998cited by this paper
• C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.

  1998cited by this paper
• C cell hyperplasia/neoplasia.

  1997cited by this paper
• Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group.

  1997cited by this paper
• Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma [4]

  1997cited by this paper
• Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d'Etude des Tumeurs a Calcitonine.

  1997cited by this paper
• Physiologic versus neoplastic C‐cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities

  1996cited by this paper
• The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

  1996cited by this paper
• Immunostains for collagen type IV discriminate between C-cell hyperplasia and microscopic medullary carcinoma in multiple endocrine neoplasia, type 2a.

  1995cited by this paper
• Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinoma

  1995cited by this paper
• Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules

  1995cited by this paper
• Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

  1994cited by this paper
• Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.

  1994cited by this paper
• Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A

  1994cited by this paper
• Distribution of C cells in the normal and diseased thyroid gland.

  1993cited by this paper
• Tumors of the thyroid gland

  1992cited by this paper
• Management of hyperparathyroidism.

  1977cited by this paper
• C-cell hyperplasia preceding medullary thyroid carcinoma.

  1973cited by this paper
• Atlas of tumor pathology

  1954cited by this paper
• Cáncer

  1939cited by this paper
• CLINICS 2012;67(S1):69-75 DOI:10.6061/clinics/2012(Sup01)13 REVIEW

  year unknowncited by this paper

• Integration molekularer, genetischer und chirurgischer Erkenntnisse in die Indikationsstellung zur präventiven Schilddrüsenchirurgie

  2025cites this paper
• Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?

  2024cites this paper
• Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

  2022cites this paper
• Thyroid Carcinoma, Version 2.2022

  2022cites this paper
• Distribution of RET proto‐oncogene variants in children with appendicitis

  2022cites this paper
• Calcitonin Stimulation Tests: Rationale, Technical Issues and Side Effects: A Review

  2021cites this paper
• Multiple Endocrine Neoplasia-Type 2

  2021cites this paper
• Safety of calcitonin stimulation tests with calcium

  2021cites this paper
• Hereditäres medulläres Schilddrüsenkarzinom

  2021cites this paper
• Endokrine und neuroendokrine Tumoren

  2021cites this paper
• Medullary Thyroid Carcinoma: Diagnosis and Treatment of Sporadic and Hereditary Tumors

  2021cites this paper
• Néoplasie endocrinienne multiple de type 2

  2020cites this paper
• Pediatric Thyroid Cancer

  2020cites this paper
• Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.

  2019cites this paper
• Multiple Endocrine Neoplasia-Type 2

  2019cites this paper
• Calcium-stimulated calcitonin - The “new standard” in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an “old test”

  2018cites this paper
• Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma

  2018cites this paper
• Clinical evaluation and treatment of phaeochromocytoma

  2018cites this paper
• A germline RET proto-oncogene mutation in multiple members of an Arab family with variable onset of MEN type 2A-associated clinical manifestations

  2017cites this paper
• A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in RET exon 11

  2017cites this paper
• MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit

  2017cites this paper
• PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.

  2017cites this paper
• Moderate-Risk versus High-Risk RET Mutation Does Not Impact Medullary Thyroid Cancer Outcomes in MEN2A Patients

  2017cites this paper
• Recent advances in the management of endocrine malignancies associated with hereditary hyperparathyroidism syndromes

  2017cites this paper
• A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma

  2016cites this paper
• Clinical Presentation and Diagnosis of Neuroendocrine Tumors.

  2016cites this paper
• Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations.

  2016cites this paper
• Chapter 96 – Surgery of the Thyroid

  2016cites this paper
• Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines

  2016cites this paper
• Surgical Management of Inherited MTC: Therapeutic Thyroidectomy

  2016cites this paper
• Prophylactic thyroidectomy results among RET germline mutation bearers in families with hereditary forms of medullary thyroid cancer

  2016cites this paper
• Endocrine neoplasms in familial syndromes of hyperparathyroidism.

  2015cites this paper
• Tiroidectomía total profiláctica en un niño de 5 años, asintomático, con neoplasia endocrina múltiple tipo 2A

  2015cites this paper
• Multiple endocrine neoplasia syndromes 1 and 2: manifestations and management in childhood and adolescence

  2015cites this paper
• Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2

  2015influential citation
• The European Society of Endocrine Surgeons perspective of thyroid cancer surgery: an evidence-based approach

  2014cites this paper
• Cutaneous Metastasis of Medullary Carcinoma Thyroid Masquerading as Subcutaneous Nodules Anterior Chest and Mandibular Region

  2014cites this paper